Urolithin A mitigates doxorubicin-induced myocardial injury via suppression of ROS-driven apoptotic signaling.

Song W, Chen M, Pang L, Wu J, Zhao X, Ma T, Zhang P, Yang H, Wang X

Open source

DOI
10.14670/hh-25-054
Published
2026 Sep
Container
Histology and histopathology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.14670/hh-25-054,
  title = {Urolithin A mitigates doxorubicin-induced myocardial injury via suppression of ROS-driven apoptotic signaling.},
  author = {Song W and Chen M and Pang L and Wu J and Zhao X and Ma T and Zhang P and Yang H and Wang X},
  year = {2026},
  journal = {Histology and histopathology},
  doi = {10.14670/hh-25-054},
  url = {https://doi.org/10.14670/hh-25-054}
}

RIS

TY  - JOUR
TI  - Urolithin A mitigates doxorubicin-induced myocardial injury via suppression of ROS-driven apoptotic signaling.
AU  - Song W
AU  - Chen M
AU  - Pang L
AU  - Wu J
AU  - Zhao X
AU  - Ma T
AU  - Zhang P
AU  - Yang H
AU  - Wang X
PY  - 2026
JO  - Histology and histopathology
DO  - 10.14670/hh-25-054
UR  - https://doi.org/10.14670/hh-25-054
ER  - 

APA

W, S., M, C., L, P., J, W., X, Z., T, M., P, Z., H, Y., & X, W. (2026). Urolithin A mitigates doxorubicin-induced myocardial injury via suppression of ROS-driven apoptotic signaling.. Histology and histopathology. https://doi.org/10.14670/hh-25-054

Source records